NL8202868A - Werkwijze voor de uitvoering van een immunobepaling. - Google Patents

Werkwijze voor de uitvoering van een immunobepaling. Download PDF

Info

Publication number: NL8202868A
Authority: NL; Netherlands
Prior art keywords: immunoassay; mixing; mixer; separators; lidex
Prior art date: 1981-07-20

Application number

NL8202868A

Other languages

English (en)

Dutch (nl)

Original Assignee

Cais Michael

Shimoni Moshe Dr

Technion Res & Dev Foundation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1981-07-20

Filing date

1982-07-15

Publication date

1983-02-16

1982-07-15 Application filed by Cais Michael, Shimoni Moshe Dr, Technion Res & Dev Foundation filed Critical Cais Michael

1983-02-16 Publication of NL8202868A publication Critical patent/NL8202868A/nl

Links

238000000034 method Methods 0.000 title claims description 96
239000003153 chemical reaction reagent Substances 0.000 claims description 27
238000002156 mixing Methods 0.000 claims description 27
238000003018 immunoassay Methods 0.000 claims description 26
238000000926 separation method Methods 0.000 claims description 20
230000008569 process Effects 0.000 claims description 14
238000005119 centrifugation Methods 0.000 claims description 13
230000033001 locomotion Effects 0.000 claims description 13
239000012071 phase Substances 0.000 claims description 9
239000007790 solid phase Substances 0.000 claims description 9
238000003127 radioimmunoassay Methods 0.000 claims description 7
230000004888 barrier function Effects 0.000 claims description 6
239000002184 metal Substances 0.000 claims description 6
229910052751 metal Inorganic materials 0.000 claims description 6
102000008857 Ferritin Human genes 0.000 claims description 5
108050000784 Ferritin Proteins 0.000 claims description 5
238000008416 Ferritin Methods 0.000 claims description 5
229960005156 digoxin Drugs 0.000 claims description 5
LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 claims description 4
LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 claims description 4
LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 claims description 4
238000007789 sealing Methods 0.000 claims description 4
229940034208 thyroxine Drugs 0.000 claims description 4
VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims description 3
XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 claims description 3
239000000427 antigen Substances 0.000 claims description 3
102000036639 antigens Human genes 0.000 claims description 3
108091007433 antigens Proteins 0.000 claims description 3
229960005309 estradiol Drugs 0.000 claims description 3
229930182833 estradiol Natural products 0.000 claims description 3
229940011871 estrogen Drugs 0.000 claims description 3
239000000262 estrogen Substances 0.000 claims description 3
XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 claims description 3
230000002485 urinary effect Effects 0.000 claims description 3
102000004190 Enzymes Human genes 0.000 claims description 2
108090000790 Enzymes Proteins 0.000 claims description 2
238000005259 measurement Methods 0.000 claims description 2
238000012800 visualization Methods 0.000 claims description 2
230000006835 compression Effects 0.000 claims 4
238000007906 compression Methods 0.000 claims 4
229940125717 barbiturate Drugs 0.000 claims 1
238000003271 compound fluorescence assay Methods 0.000 claims 1
229940079593 drug Drugs 0.000 claims 1
239000003814 drug Substances 0.000 claims 1
238000001952 enzyme assay Methods 0.000 claims 1
229940088597 hormone Drugs 0.000 claims 1
239000005556 hormone Substances 0.000 claims 1
150000003431 steroids Chemical class 0.000 claims 1
239000003204 tranquilizing agent Substances 0.000 claims 1
230000002936 tranquilizing effect Effects 0.000 claims 1
239000011782 vitamin Substances 0.000 claims 1
229940088594 vitamin Drugs 0.000 claims 1
229930003231 vitamin Natural products 0.000 claims 1
235000013343 vitamin Nutrition 0.000 claims 1
WJOHZNCJWYWUJD-IUGZLZTKSA-N Fluocinonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)C)[C@@]2(C)C[C@@H]1O WJOHZNCJWYWUJD-IUGZLZTKSA-N 0.000 description 40
238000003556 assay Methods 0.000 description 19
229920001223 polyethylene glycol Polymers 0.000 description 15
238000012360 testing method Methods 0.000 description 14
238000009739 binding Methods 0.000 description 12
238000002474 experimental method Methods 0.000 description 10
230000027455 binding Effects 0.000 description 9
239000003446 ligand Substances 0.000 description 9
239000007791 liquid phase Substances 0.000 description 9
239000012528 membrane Substances 0.000 description 8
210000002966 serum Anatomy 0.000 description 8
230000009870 specific binding Effects 0.000 description 8
238000011534 incubation Methods 0.000 description 7
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
238000000159 protein binding assay Methods 0.000 description 5
241000227653 Lycopersicon Species 0.000 description 4
235000007688 Lycopersicon esculentum Nutrition 0.000 description 4
JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
239000007788 liquid Substances 0.000 description 4
238000001556 precipitation Methods 0.000 description 4
238000000638 solvent extraction Methods 0.000 description 4
238000003756 stirring Methods 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 3
230000007246 mechanism Effects 0.000 description 3
238000007639 printing Methods 0.000 description 3
230000002285 radioactive effect Effects 0.000 description 3
239000007787 solid Substances 0.000 description 3
239000002904 solvent Substances 0.000 description 3
238000012546 transfer Methods 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
102000004877 Insulin Human genes 0.000 description 2
108090001061 Insulin Proteins 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
239000003463 adsorbent Substances 0.000 description 2
235000013405 beer Nutrition 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
238000010908 decantation Methods 0.000 description 2
239000012530 fluid Substances 0.000 description 2
229960000890 hydrocortisone Drugs 0.000 description 2
229940125396 insulin Drugs 0.000 description 2
239000002245 particle Substances 0.000 description 2
230000035515 penetration Effects 0.000 description 2
238000005191 phase separation Methods 0.000 description 2
229960003387 progesterone Drugs 0.000 description 2
239000000186 progesterone Substances 0.000 description 2
238000001179 sorption measurement Methods 0.000 description 2
229960003604 testosterone Drugs 0.000 description 2
PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 description 1
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 1
241000283707 Capra Species 0.000 description 1
102100021022 Gastrin Human genes 0.000 description 1
108010052343 Gastrins Proteins 0.000 description 1
101000904173 Homo sapiens Progonadoliberin-1 Proteins 0.000 description 1
101150109329 PETO gene Proteins 0.000 description 1
239000007990 PIPES buffer Substances 0.000 description 1
102100024028 Progonadoliberin-1 Human genes 0.000 description 1
102000003946 Prolactin Human genes 0.000 description 1
108010057464 Prolactin Proteins 0.000 description 1
101000996723 Sus scrofa Gonadotropin-releasing hormone receptor Proteins 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
238000004220 aggregation Methods 0.000 description 1
230000002776 aggregation Effects 0.000 description 1
238000013019 agitation Methods 0.000 description 1
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
229910052921 ammonium sulfate Inorganic materials 0.000 description 1
235000011130 ammonium sulphate Nutrition 0.000 description 1
238000013459 approach Methods 0.000 description 1
229940056861 bidex Drugs 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
239000005082 bioluminescent agent Substances 0.000 description 1
239000003610 charcoal Substances 0.000 description 1
AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
239000005081 chemiluminescent agent Substances 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
230000000694 effects Effects 0.000 description 1
229960001348 estriol Drugs 0.000 description 1
PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
125000000524 functional group Chemical group 0.000 description 1
XLXSAKCOAKORKW-UHFFFAOYSA-N gonadorelin Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 XLXSAKCOAKORKW-UHFFFAOYSA-N 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
239000006193 liquid solution Substances 0.000 description 1
238000004020 luminiscence type Methods 0.000 description 1
238000003754 machining Methods 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
239000000203 mixture Substances 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
238000005457 optimization Methods 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
238000003825 pressing Methods 0.000 description 1
238000012545 processing Methods 0.000 description 1
239000000047 product Substances 0.000 description 1
229940097325 prolactin Drugs 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
230000005855 radiation Effects 0.000 description 1
150000003254 radicals Chemical class 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000004044 response Effects 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
238000012216 screening Methods 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
150000004760 silicates Chemical class 0.000 description 1
229910000679 solder Inorganic materials 0.000 description 1
238000002764 solid phase assay Methods 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
-1 β-hGG Proteins 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/80—Fluorescent dyes, e.g. rhodamine
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/801—Electron dense compounds, e.g. ferritin
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/804—Radioisotope, e.g. radioimmunoassay
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/808—Automated or kit
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/809—Multifield plates or multicontainer arrays
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/81—Tube, bottle, or dipstick
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/814—Pregnancy
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/824—Immunological separation techniques

Landscapes

Health & Medical Sciences (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Food Science & Technology (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Investigating Or Analysing Biological Materials (AREA)
Sampling And Sample Adjustment (AREA)
Automatic Analysis And Handling Materials Therefor (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

NL8202868A 1981-07-20 1982-07-15 Werkwijze voor de uitvoering van een immunobepaling. NL8202868A (nl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IL63363A IL63363A (en)	1981-07-20	1981-07-20	Non-centrifugation method for immunoassay of materials
IL6336381		1981-07-20

Publications (1)

Publication Number	Publication Date
NL8202868A true NL8202868A (nl)	1983-02-16

Family

ID=11052790

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL8202868A NL8202868A (nl)	1981-07-20	1982-07-15	Werkwijze voor de uitvoering van een immunobepaling.

Country Status (16)

Country	Link
US (2)	US4456690A (pt)
JP (1)	JPS5870165A (pt)
AT (1)	AT385130B (pt)
AU (1)	AU556063B2 (pt)
BE (1)	BE893688A (pt)
BR (1)	BR8204053A (pt)
CA (1)	CA1178198A (pt)
CH (1)	CH658130A5 (pt)
DE (1)	DE3225043A1 (pt)
FR (1)	FR2509862A1 (pt)
GB (1)	GB2105036B (pt)
IL (1)	IL63363A (pt)
IT (1)	IT1151972B (pt)
NL (1)	NL8202868A (pt)
SE (1)	SE8204361L (pt)
ZA (1)	ZA824278B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL56839A0 (en) *	1979-03-11	1979-05-31	Technion Res & Dev Foundation	Improvement in specific binding assay technique
US4800020A (en) *	1987-05-21	1989-01-24	Xydex Corporation	Piston filtering device
US4921618A (en) *	1987-07-01	1990-05-01	Basf Corporation	Inverted separation and transfer device, and process for using same
US5256372A (en) *	1987-11-06	1993-10-26	Idexx Corporation	Dipstick test device including a removable filter assembly
US4990253A (en) *	1988-01-25	1991-02-05	Abbott Laboratories	Fluid sample filtration device
US4891134A (en) *	1988-01-25	1990-01-02	Abbott Laboratories	Sample filtration device
US5279968A (en) *	1989-07-20	1994-01-18	Syncor International Corporation	Method of labelling leucocytes with Tc-99m, d,1-HMPAO
US5114858A (en) *	1990-06-26	1992-05-19	E. I. Du Pont De Nemours And Company	Cellular component extraction process in a disposable filtration vessel
EP0601173B1 (en) *	1992-06-29	1997-03-05	Dade International Inc.	Sample tube carrier
US5571481A (en) *	1995-02-17	1996-11-05	Vicam, L.P.	Magnetic capture rack with slidable magnetic member
US5900377A (en) *	1997-03-03	1999-05-04	Syncor International Corporation	Method for isolating and radiolabeling leukocytes for use in vivo
US6184040B1 (en)	1998-02-12	2001-02-06	Polaroid Corporation	Diagnostic assay system and method
US6495373B1 (en)	1998-10-14	2002-12-17	Polaroid Corporation	Method and apparatus for performing diagnostic tests
US6331715B1 (en)	1998-10-14	2001-12-18	Polaroid Corporation	Diagnostic assay system and method having a luminescent readout signal
US6555060B1 (en) *	1998-10-14	2003-04-29	Polaroid Corporation	Apparatus for performing diagnostic testing
US6432358B2 (en)	1999-01-27	2002-08-13	Polaroid Corporation	Diagnostic assay device
US6328930B1 (en)	1999-02-11	2001-12-11	Polaroid Corporation	Apparatus for performing diagnostic testing
US6193892B1 (en)	1999-03-03	2001-02-27	Promega Corporation	Magnetic separation assembly and method
DE19923307B4 (de) *	1999-05-20	2005-03-31	Beka-Tore, Knörzer GmbH	Garagenbauwerk
US6641782B1 (en)	2000-11-15	2003-11-04	Polaroid Corporation	Apparatus for performing diagnostic testing
GB201111080D0 (en) *	2011-06-29	2011-08-10	Ge Healthcare Uk Ltd	Syringeless filter device compressor
US12128334B2 (en) *	2018-09-05	2024-10-29	Kin Mun Chin	Filter press with threadably advanced filtrate receiving plunger

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2524362A (en) *	1947-07-19	1950-10-03	Arthur E Smith	Disposable ampoule syringe
US3068855A (en) *	1957-04-29	1962-12-18	Jr Norman B Furlong	Disposable blood-gas analyzer
US3449081A (en) *	1965-03-29	1969-06-10	Electronic Instr Co	Test kit
FR2274918A1 (fr) *	1974-03-30	1976-01-09	Sarstedt Kunststoff	Dispositif de filtrage pour la separation de fractions de sang
DE2422260B2 (de) *	1974-05-08	1979-04-12	Compur-Electronic Gmbh, 8000 Muenchen	Einrichtung zur Herstellung einer optisch zu untersuchenden Meßflüssigkeit
US3969250A (en) *	1975-03-10	1976-07-13	Farr Andrew F	Apparatus for preparing liquid samples for analysis in automatic analyzers
US4087248A (en) *	1976-07-26	1978-05-02	Miles Laughton E	Multiple assay machine and method
DE2637273B2 (de) *	1976-08-19	1979-02-15	Walter Sarstedt Kunststoff-Spritzgusswerk, 5223 Nuembrecht	Vorrichtung zum Trennen von Blutfraktionen
US4090850A (en) *	1976-11-01	1978-05-23	E. R. Squibb & Sons, Inc.	Apparatus for use in radioimmunoassays
US4071319A (en) *	1976-11-26	1978-01-31	Becton, Dickinson And Company	Contaminant detector
US4197287A (en) *	1977-06-10	1980-04-08	Ventrex Laboratories Inc.	Method and apparatus for performing in nitro clinical diagnostic tests using a solid phase assay system having special utility for use with automatic pipetting equipment
DE2731028C2 (de) *	1977-07-08	1986-09-04	Thoma, Hans A., Dipl.-Chem. Dr., 8000 München	Verwendung eines Antikörpergels zur immunologischen Bestimmung von Hormonen, Pharmaka und Vitaminen, welche in ungebundenem Zustand vorliegen
JPS54111892A (en) *	1978-02-17	1979-09-01	Ii Mairusu Rooton	Method and device for inspecting numerous data
US4254082A (en) *	1978-06-12	1981-03-03	Miles Laboratories, Inc.	Specific binding-adsorbent assay test means
IL58943A (en) *	1979-12-12	1983-05-15	Cais Michael	Method and device for mass transfer operations in immunoassays and other applications
IL60645A (en) *	1980-07-21	1984-02-29	Cais Michael	Method and device for mass transfer and separation through selective barriers

1981
- 1981-07-20 IL IL63363A patent/IL63363A/xx not_active IP Right Cessation
1982
- 1982-06-17 ZA ZA824278A patent/ZA824278B/xx unknown
- 1982-06-29 IT IT22140/82A patent/IT1151972B/it active
- 1982-06-29 US US06/393,397 patent/US4456690A/en not_active Expired - Fee Related
- 1982-06-29 CA CA000406292A patent/CA1178198A/en not_active Expired
- 1982-06-29 BE BE0/208480A patent/BE893688A/fr not_active IP Right Cessation
- 1982-07-05 DE DE19823225043 patent/DE3225043A1/de not_active Withdrawn
- 1982-07-07 CH CH4829/82A patent/CH658130A5/de not_active IP Right Cessation
- 1982-07-08 GB GB08219818A patent/GB2105036B/en not_active Expired
- 1982-07-09 AT AT0269182A patent/AT385130B/de not_active IP Right Cessation
- 1982-07-13 BR BR8204053A patent/BR8204053A/pt not_active IP Right Cessation
- 1982-07-15 FR FR8212372A patent/FR2509862A1/fr active Pending
- 1982-07-15 NL NL8202868A patent/NL8202868A/nl not_active Application Discontinuation
- 1982-07-16 SE SE8204361A patent/SE8204361L/xx not_active Application Discontinuation
- 1982-07-19 AU AU86172/82A patent/AU556063B2/en not_active Ceased
- 1982-07-20 JP JP57125186A patent/JPS5870165A/ja active Pending
1983
- 1983-12-30 US US06/567,003 patent/US4587221A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
SE8204361D0 (sv)	1982-07-16
ATA269182A (de)	1987-07-15
DE3225043A1 (de)	1983-02-10
US4456690A (en)	1984-06-26
IT8222140A0 (it)	1982-06-29
CH658130A5 (de)	1986-10-15
CA1178198A (en)	1984-11-20
BE893688A (fr)	1982-10-18
SE8204361L (sv)	1983-01-21
AU8617282A (en)	1983-01-27
BR8204053A (pt)	1983-07-05
IT1151972B (it)	1986-12-24
IL63363A0 (en)	1981-10-30
ZA824278B (en)	1983-04-27
AT385130B (de)	1988-02-25
FR2509862A1 (fr)	1983-01-21
IL63363A (en)	1986-08-31
GB2105036B (en)	1985-08-21
JPS5870165A (ja)	1983-04-26
US4587221A (en)	1986-05-06
AU556063B2 (en)	1986-10-23
GB2105036A (en)	1983-03-16

Publication	Publication Date	Title
NL8202868A (nl)	1983-02-16	Werkwijze voor de uitvoering van een immunobepaling.
US20190086324A1 (en)	2019-03-21	Systems and Methods for Multianalyte Detection
GB2025046A (en)	1980-01-16	Solid phase assays
EP0030087A1 (en)	1981-06-10	Immunoassay method and apparatus and kit for carrying out the method
JP2008203279A (ja)	2008-09-04	自動測定用カートリッジ
US10845278B2 (en)	2020-11-24	Method and apparatus for automated analysis
JPWO2001084152A1 (ja)	2003-07-29	自動測定用カートリッジおよびそれを用いる測定法
EP3566771B1 (en)	2023-09-06	Laboratory system and method for separating interfering substances contained in test samples
JP5456765B2 (ja)	2014-04-02	試験要素のスプリットスピン遠心分離
GB1574642A (en)	1980-09-10	Automated immunoassay
US20180120204A1 (en)	2018-05-03	Method and apparatus for automated analysis
Ratcliffe et al.	1982	Direct 125I-radioligand assays for serum progesterone compared with assays involving extraction of serum.
NL8003294A (nl)	1980-12-09	Werkwijze voor het bepalen van een antigeen, antilichaam of antigeenantilichaamcomplex alsmede daarvoor bestemde meetkit.
CN112394185A (zh)	2021-02-23	参考物质位置分配方法及样本分析系统
US4454231A (en)	1984-06-12	Method and device for mass transfer operation in immunoassays and other applications
EP2881740B1 (en)	2019-02-13	A method for quantifying an analyte, and an automatic analytical device configured to implement said method
Pourfarzaneh et al.	1982	The use of magnetizable particles in solid phase immunoassay
WO1995019569A1 (en)	1995-07-20	Reaction columns for simultaneous multiple measurement and method
US20050106564A1 (en)	2005-05-19	One-step, no-wash multiplex bead-based flow cytometric assay
Strott	1975	[3] Use of plasma-binding proteins for steroid hormone assays
US20220326271A1 (en)	2022-10-13	Methods for onboard dilutions using automated analyzer
Truchaud et al.	1991	New trends for automation in immunoassays
Heub et al.	2016	A Simple Method for Automated Solid Phase Extraction of Water Samples for Immunological Analysis of Small Pollutants
Demers	1992	SR1 Immunoassay System
Simons et al.	2018	Automation of Radioimmunoassay With the Picker Pace-4® System

Legal Events

Date	Code	Title
1985-01-01	A85	Still pending on 85-01-01
1989-09-01	BA	A request for search or an international-type search has been filed
1989-12-01	BB	A search report has been drawn up
1990-04-02	BC	A request for examination has been filed
1995-03-01	BV	The patent application has lapsed